Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Type of study
Language
Affiliation country
Publication year range
1.
Sci Rep ; 11(1): 10411, 2021 05 17.
Article in English | MEDLINE | ID: mdl-34002002

ABSTRACT

TRPM4 is a calcium-activated non-selective monovalent cation channel implicated in diseases such as stroke. Lack of potent and selective inhibitors remains a major challenge for studying TRPM4. Using a polypeptide from rat TRPM4, we have generated a polyclonal antibody M4P which could alleviate reperfusion injury in a rat model of stroke. Here, we aim to develop a monoclonal antibody that could block human TRPM4 channel. Two mouse monoclonal antibodies M4M and M4M1 were developed to target an extracellular epitope of human TRPM4. Immunohistochemistry and western blot were used to characterize the binding of these antibodies to human TRPM4. Potency of inhibition was compared using electrophysiological methods. We further evaluated the therapeutic potential on a rat model of middle cerebral artery occlusion. Both M4M and M4M1 could bind to human TRPM4 channel on the surface of live cells. Prolonged incubation with TRPM4 blocking antibody internalized surface TRPM4. Comparing to M4M1, M4M is more effective in blocking human TRPM4 channel. In human brain microvascular endothelial cells, M4M successfully inhibited TRPM4 current and ameliorated hypoxia-induced cell swelling. Using wild type rats, neither antibody demonstrated therapeutic potential on stroke. Human TRPM4 channel can be blocked by a monoclonal antibody M4M targeting a key antigenic sequence. For future clinical translation, the antibody needs to be humanized and a transgenic animal carrying human TRPM4 sequence is required for in vivo characterizing its therapeutic potential.


Subject(s)
Antibodies, Monoclonal/pharmacology , Infarction, Middle Cerebral Artery/drug therapy , Reperfusion Injury/prevention & control , TRPM Cation Channels/antagonists & inhibitors , Animals , Antibodies, Monoclonal/therapeutic use , Brain/cytology , Brain/drug effects , Brain/pathology , Disease Models, Animal , Drug Evaluation, Preclinical , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Endothelial Cells/pathology , HEK293 Cells , Humans , Infarction, Middle Cerebral Artery/complications , Male , Patch-Clamp Techniques , Rats , Reperfusion Injury/etiology , Reperfusion Injury/pathology , TRPM Cation Channels/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL